313 related articles for article (PubMed ID: 26206828)
1. Use of the Combined First-Trimester Screen in High- and Low-Risk Patient Populations After Introduction of Noninvasive Prenatal Testing.
Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
J Ultrasound Med; 2015 Aug; 34(8):1423-8. PubMed ID: 26206828
[TBL] [Abstract][Full Text] [Related]
2. Uptake of noninvasive prenatal testing at a large academic referral center.
Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
Am J Obstet Gynecol; 2014 Dec; 211(6):651.e1-7. PubMed ID: 24954652
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive prenatal testing for fetal trisomy in a mixed risk factors pregnancy population.
Li WH; Wang PH; Chuang CM; Chang YW; Yang MJ; Chen CY; Chao KC; Yen MS
Taiwan J Obstet Gynecol; 2015 Apr; 54(2):122-5. PubMed ID: 25951714
[TBL] [Abstract][Full Text] [Related]
4. Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies.
O'Leary P; Maxwell S; Murch A; Hendrie D
Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):425-33. PubMed ID: 24090461
[TBL] [Abstract][Full Text] [Related]
5. An update on current prenatal testing options: first trimester and noninvasive prenatal testing.
Latendresse G; Deneris A
J Midwifery Womens Health; 2015; 60(1):24-36; quiz 111. PubMed ID: 25712277
[TBL] [Abstract][Full Text] [Related]
6. Prenatal diagnostic testing and atypical chromosome abnormalities following combined first-trimester screening: implications for contingent models of non-invasive prenatal testing.
Lindquist A; Poulton A; Halliday J; Hui L
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):487-492. PubMed ID: 29226487
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal microarray as primary diagnostic genomic tool for pregnancies at increased risk within a population-based combined first-trimester screening program.
Vogel I; Petersen OB; Christensen R; Hyett J; Lou S; Vestergaard EM
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):480-486. PubMed ID: 28608362
[TBL] [Abstract][Full Text] [Related]
8. The potential impact of NIPT as a second-tier screen on the outcomes of high-risk pregnancies with rare chromosomal abnormalities.
Maxwell S; Dickinson JE; Murch A; O'Leary P
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):420-6. PubMed ID: 26286670
[TBL] [Abstract][Full Text] [Related]
9. From Down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan.
Shaw SW; Chen CP; Cheng PJ
Taiwan J Obstet Gynecol; 2013 Dec; 52(4):470-4. PubMed ID: 24411028
[TBL] [Abstract][Full Text] [Related]
10. A new era in prenatal care: non-invasive prenatal testing in Switzerland.
Manegold-Brauer G; Kang Bellin A; Hahn S; De Geyter C; Buechel J; Hoesli I; Lapaire O
Swiss Med Wkly; 2014 Feb; 144():w13915. PubMed ID: 24549748
[TBL] [Abstract][Full Text] [Related]
11. Uptake of non-invasive prenatal testing (NIPT) and impact on invasive procedures in a tertiary referral center.
Manegold-Brauer G; Berg C; Flöck A; Rüland A; Gembruch U; Geipel A
Arch Gynecol Obstet; 2015 Sep; 292(3):543-8. PubMed ID: 25716672
[TBL] [Abstract][Full Text] [Related]
12. Association of combined first-trimester screen and noninvasive prenatal testing on diagnostic procedures.
Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
Obstet Gynecol; 2014 Jun; 123(6):1303-1310. PubMed ID: 24807333
[TBL] [Abstract][Full Text] [Related]
13. The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort.
Li SW; Barrett AN; Gole L; Tan WC; Biswas A; Tan HK; Choolani M
Singapore Med J; 2015 Jan; 56(1):47-52. PubMed ID: 25640099
[TBL] [Abstract][Full Text] [Related]
14. Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis.
Fairbrother G; Burigo J; Sharon T; Song K
J Matern Fetal Neonatal Med; 2016; 29(7):1160-4. PubMed ID: 26000626
[TBL] [Abstract][Full Text] [Related]
15. Questioning the costs and benefits of non-invasive prenatal testing.
Stoll K; Lutgendorf M; Knutzen D; Nielsen PE
J Matern Fetal Neonatal Med; 2014 Apr; 27(6):633-4. PubMed ID: 23808328
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population.
Song K; Musci TJ; Caughey AB
J Matern Fetal Neonatal Med; 2013 Aug; 26(12):1180-5. PubMed ID: 23356557
[TBL] [Abstract][Full Text] [Related]
17. Sex chromosome aneuploidy detection by noninvasive prenatal testing: helpful or hazardous?
Reiss RE; Discenza M; Foster J; Dobson L; Wilkins-Haug L
Prenat Diagn; 2017 May; 37(5):515-520. PubMed ID: 28326560
[TBL] [Abstract][Full Text] [Related]
18. Potential diagnostic consequences of applying non-invasive prenatal testing: population-based study from a country with existing first-trimester screening.
Petersen OB; Vogel I; Ekelund C; Hyett J; Tabor A; ;
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):265-71. PubMed ID: 24375770
[TBL] [Abstract][Full Text] [Related]
19. First trimester screening cut-offs for noninvasive prenatal testing as a contingent screen: Balancing detection and screen-positive rates for trisomy 21.
Maxwell S; James I; Dickinson JE; O'Leary P
Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):29-35. PubMed ID: 26749261
[TBL] [Abstract][Full Text] [Related]
20. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
